Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report? [Yahoo! Finance]
Allogene Therapeutics, Inc. (ALLO)
Last allogene therapeutics, inc. earnings: 2/27 04:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Allogene Therapeutics due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Allogene Therapeutics, Inc. before we dive into how investors and analysts have reacted as of late. Narrower Than Expected Loss in Q1, Nil Sales Allogene incurred a first-quarter 2026 loss of 18 cents per share, narrower than the Zacks Consensus Estimate of a loss of 19 cents. In the year-ago period, the company reported a loss of 28 cents. The company did not report any sales during the quarter, as it lacks a marketed product in its portfolio. Quarter in Detail Research & development (R&D) expenses totaled $32 million, down 36% from the year-ago quarter's level. General and administrative (G&A) expenses declined 6% to $14.1 million. As of March 31, 2026, Allogene had $266.9 million in
Show less
Read more
Impact Snapshot
Event Time:
ALLO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALLO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALLO alerts
High impacting Allogene Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ALLO
News
- Allogene Therapeutics: A High-Upside Bet On The Next Wave Of CAR-T Innovation [Seeking Alpha]Seeking Alpha
- Allogene Therapeutics (ALLO) Stock Gets Fair Value Boost After Split Analyst Revisions [Yahoo! Finance]Yahoo! Finance
- Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio [Yahoo! Finance]Yahoo! Finance
- Allogene Therapeutics Announces Planned CEO Succession [Yahoo! Finance]Yahoo! Finance
- Allogene Therapeutics Announces Planned CEO SuccessionGlobeNewswire
ALLO
Earnings
- 5/13/26 - Beat
ALLO
Sec Filings
- 7/6/26 - Form 4
- 6/23/26 - Form 4
- 6/23/26 - Form 4
- ALLO's page on the SEC website